
Opinion|Videos|April 1, 2024
Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM
Panelists summarize key takeaways on using bispecific antibodies for multiple myeloma treatment.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Denosumab Biosimilars Boncresa and Oziltus for Osteoporosis-, Cancer-Related Bone Loss
2
'Beyond Weight Loss': Emerging Studies Show How GLP-1 Receptor Agonists May Impact Addiction Behaviors
3
Tradipitant Becomes First Treatment Approved for Vomiting Due to Motion Sickness in 4 Decades
4
New Drug Approach Targets KRAS-Mutant Lung Cancer to Overcome Therapy Resistance
5













































































































































































































